# Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema

> **NCT01194674** · PHASE1,PHASE2 · TERMINATED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 2 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Microplasmin

## Key facts

- **NCT ID:** NCT01194674
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Lack of enrollment.
- **Last updated:** 2018-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01194674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01194674, "Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01194674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*